SCHEMBL21030550

SCHEMBL21030550

Cn1c2ccccc2c2cc(-c3ccc4c(c3)c3c5ccccc5ccc3n4-c3ccc4ccccc4c3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GPR3 P46089 1/20 0.39
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21032320 0.98 KDM4E (0.42) KDM4EMAPTL3MBTL1MEN1ALDH1A1
SCHEMBL17562216 0.94 KDM4E (0.39) KDM4EL3MBTL1ALDH1A1HPGDTUBB4A
SCHEMBL21031225 0.92 KDM4E (0.48) KDM4EMAPTL3MBTL1MEN1ALDH1A1
SCHEMBL25847214 0.90 KDM4E (0.41) KDM4EMAPTL3MBTL1MEN1ALDH1A1
SCHEMBL16838882 0.90 KDM4E (0.46) KDM4EMAPTL3MBTL1MEN1ALDH1A1
SCHEMBL18088947 0.90 KDM4E (0.46) KDM4EL3MBTL1ALDH1A1HPGDKMT2A
SCHEMBL16542846 0.90 KDM4E (0.46) KDM4EL3MBTL1ALDH1A1HPGDKMT2A
SCHEMBL17562182 0.90 MAPK10 (0.37) KDM4EL3MBTL1ALDH1A1HPGDTUBB4A
SCHEMBL19829067 0.89 KDM4E (0.45) KDM4EL3MBTL1HPGDTUBB4ATUBB
SCHEMBL26416277 0.89 KDM4E (0.41) KDM4EL3MBTL1HPGDTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 KDM4E 962/4885MAPT 611/4885L3MBTL1 1618/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 KDM4E 962/4885MAPT 611/4885L3MBTL1 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.